Shanghai Yaxin Biotechnology company was founded in
2008,which is a high-tech enterprise that focuses on researching
and producing the recombinant proteins.YaxinBio is the first and
only a company on researching and producing the recombinant
carboxypeptidase B and recombinant trypsin.Animal original free
enzymes are specially used in the human recombinant insulin
production,and exporting abroad.
Recombinant trypsin is used in the cell
culturing process,which conforms to the 2014 USP on the usage of
trypsin in the cell culture.Animal original free is very important
for the production of antibody and vaccine.Usage of recombinat
trypsin fundamentally solves the problem of animal original virus
contamination in the human recombinant insulin production.
YaxinBio insists on “scientific and
technological innovation”,has developed with independent
intellectual property rights of the products.YaxinBio obtained the
support of Chinese ministry of science and technology and Shanghai
innovation fund project in 2010; Recombinant trypsin,recombinant
carboxypeptidase B and recombinant protein A won the Shanghai
high-tech achievement transformation project in Sep.2013.